
Harris C. Wang
Examiner (ID: 9046, Phone: (571)270-1462 , Office: P/2439 )
| Most Active Art Unit | 2439 |
| Art Unit(s) | 2139, 2439 |
| Total Applications | 625 |
| Issued Applications | 416 |
| Pending Applications | 50 |
| Abandoned Applications | 179 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12746407
[patent_doc_number] => 20180140636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => EXTRACELLULAR MATRIX FROM PLURIPOTENT CELLS
[patent_app_type] => utility
[patent_app_number] => 15/870701
[patent_app_country] => US
[patent_app_date] => 2018-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8581
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15870701
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/870701 | Extracellular matrix from pluripotent cells | Jan 11, 2018 | Issued |
Array
(
[id] => 12881125
[patent_doc_number] => 20180185550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Microporous Hydrogel Scaffolds for Cell Transplantation
[patent_app_type] => utility
[patent_app_number] => 15/863843
[patent_app_country] => US
[patent_app_date] => 2018-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15863843
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/863843 | Microporous hydrogel scaffolds for cell transplantation | Jan 4, 2018 | Issued |
Array
(
[id] => 13309887
[patent_doc_number] => 20180206480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => PROTECTION OF PROGENITOR CELLS AND REGULATION OF THEIR DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 15/861182
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861182
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861182 | Protection of progenitor cells and regulation of their differentiation | Jan 2, 2018 | Issued |
Array
(
[id] => 12880366
[patent_doc_number] => 20180185297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Serum Specific Drug Transport System
[patent_app_type] => utility
[patent_app_number] => 15/860555
[patent_app_country] => US
[patent_app_date] => 2018-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15860555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/860555 | Serum Specific Drug Transport System | Jan 1, 2018 | Abandoned |
Array
(
[id] => 15420605
[patent_doc_number] => 10543204
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Use of Hsp70 as a regulator of enzymatic activity
[patent_app_type] => utility
[patent_app_number] => 15/854352
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 47871
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15854352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/854352 | Use of Hsp70 as a regulator of enzymatic activity | Dec 25, 2017 | Issued |
Array
(
[id] => 15342661
[patent_doc_number] => 20200009222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => THERAPEUTICALLY ACTIVE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 16/468605
[patent_app_country] => US
[patent_app_date] => 2017-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16468605
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/468605 | THERAPEUTICALLY ACTIVE COMPLEXES | Dec 18, 2017 | Abandoned |
Array
(
[id] => 17266405
[patent_doc_number] => 11191809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-07
[patent_title] => Composition in powder form comprising iron-milk protein complexes and probiotic bacteria
[patent_app_type] => utility
[patent_app_number] => 16/462391
[patent_app_country] => US
[patent_app_date] => 2017-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9254
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462391
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462391 | Composition in powder form comprising iron-milk protein complexes and probiotic bacteria | Dec 13, 2017 | Issued |
Array
(
[id] => 12724606
[patent_doc_number] => 20180133369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-17
[patent_title] => INJECTABLE COMPOSITION FOR IN-SITU REPAIR AND REGENERATION OF AN INJURED LIGAMENT OR TENDON AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/837300
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18566
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837300 | Injectable composition for in-situ repair and regeneration of an injured ligament or tendon and methods of use | Dec 10, 2017 | Issued |
Array
(
[id] => 15541201
[patent_doc_number] => 10570366
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Lactic acid bacterium having IgA production promoting activity, and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/835126
[patent_app_country] => US
[patent_app_date] => 2017-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8186
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15835126
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/835126 | Lactic acid bacterium having IgA production promoting activity, and use thereof | Dec 6, 2017 | Issued |
Array
(
[id] => 17322722
[patent_doc_number] => 11213709
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Bacterial strains and consortium comprising same for degrading MTBE, TBA and/or HCHO
[patent_app_type] => utility
[patent_app_number] => 16/464962
[patent_app_country] => US
[patent_app_date] => 2017-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 12
[patent_no_of_words] => 12761
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464962 | Bacterial strains and consortium comprising same for degrading MTBE, TBA and/or HCHO | Nov 28, 2017 | Issued |
Array
(
[id] => 17512089
[patent_doc_number] => 11291200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Application of viable cell monitor to cryopreservation of plant cells
[patent_app_type] => utility
[patent_app_number] => 16/347429
[patent_app_country] => US
[patent_app_date] => 2017-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4312
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16347429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/347429 | Application of viable cell monitor to cryopreservation of plant cells | Nov 21, 2017 | Issued |
Array
(
[id] => 18700070
[patent_doc_number] => 11786556
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Method for preparing a growth factors containing platelet releasate
[patent_app_type] => utility
[patent_app_number] => 16/462452
[patent_app_country] => US
[patent_app_date] => 2017-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7087
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16462452
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/462452 | Method for preparing a growth factors containing platelet releasate | Nov 19, 2017 | Issued |
Array
(
[id] => 16191147
[patent_doc_number] => 20200231996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => PRODUCTION OF ALGAE-DERIVED POLYUNSATURATED FATTY ACIDS
[patent_app_type] => utility
[patent_app_number] => 16/652482
[patent_app_country] => US
[patent_app_date] => 2017-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9672
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16652482
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/652482 | Production of algae-derived polyunsaturated fatty acids | Nov 16, 2017 | Issued |
Array
(
[id] => 15553669
[patent_doc_number] => 20200061246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => METHODS AND MATERIALS FOR USING FIBRIN SUPPORTS FOR RETINAL PIGMENT EPITHELIUM TRANSPLANTATION
[patent_app_type] => utility
[patent_app_number] => 16/467681
[patent_app_country] => US
[patent_app_date] => 2017-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13990
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16467681
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/467681 | Methods and materials for using fibrin supports for retinal pigment epithelium transplantation | Nov 12, 2017 | Issued |
Array
(
[id] => 12751135
[patent_doc_number] => 20180142212
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-24
[patent_title] => COMPOSITIONS AND METHODS FOR ENHANCED GENERATION OF HEMATOPOIETIC STEM/PROGENITOR CELLS
[patent_app_type] => utility
[patent_app_number] => 15/804555
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46371
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15804555
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/804555 | COMPOSITIONS AND METHODS FOR ENHANCED GENERATION OF HEMATOPOIETIC STEM/PROGENITOR CELLS | Nov 5, 2017 | Abandoned |
Array
(
[id] => 12217530
[patent_doc_number] => 20180055889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-01
[patent_title] => 'TREATMENT OF HEART DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/804339
[patent_app_country] => US
[patent_app_date] => 2017-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27400
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 53
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15804339
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/804339 | Treatment of heart disease | Nov 5, 2017 | Issued |
Array
(
[id] => 17875735
[patent_doc_number] => 11447738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Methods and compositions for preserving bacteria
[patent_app_type] => utility
[patent_app_number] => 16/341583
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19083
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16341583
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/341583 | Methods and compositions for preserving bacteria | Oct 26, 2017 | Issued |
Array
(
[id] => 13593101
[patent_doc_number] => 20180348099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-06
[patent_title] => METHOD FOR LABELING CONCENTRATION DENSITY DIFFERENTIALS OF AN ANALYTE IN A BIOLOGICAL SAMPLE
[patent_app_type] => utility
[patent_app_number] => 15/720239
[patent_app_country] => US
[patent_app_date] => 2017-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15720239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/720239 | Method for labeling concentration density differentials of an analyte in a biological sample | Sep 28, 2017 | Issued |
Array
(
[id] => 12702184
[patent_doc_number] => 20180125894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => Closed System Separation of Adherent Bone Marrow Stem Cells for Regenerative Medicine Applications
[patent_app_type] => utility
[patent_app_number] => 15/714523
[patent_app_country] => US
[patent_app_date] => 2017-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5557
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15714523
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/714523 | Closed System Separation of Adherent Bone Marrow Stem Cells for Regenerative Medicine Applications | Sep 24, 2017 | Abandoned |
Array
(
[id] => 15243831
[patent_doc_number] => 10507426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-17
[patent_title] => Systems and methods for biological conversion of carbon dioxide pollutants into useful products
[patent_app_type] => utility
[patent_app_number] => 15/707780
[patent_app_country] => US
[patent_app_date] => 2017-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16571
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15707780
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/707780 | Systems and methods for biological conversion of carbon dioxide pollutants into useful products | Sep 17, 2017 | Issued |